Cytotoxic T lymphocytes (CTL) recognize antigenic peptides bound to major histocompatibility complex class I antigens on the cell surface of virus-infected cells. It is believed that the majority of peptides originate from cytoplasmic degradation of proteins assumed to be mediated by the "20S" proteasome. Cytosolic peptides are then translocated, presumably by transporters associated with antigen processing (TAP-1 and -2), into the lumen of the endoplasmic reticulum (ER) where binding and formation of the ternary complex between heavy chain, 32-microglobulin (32m) and peptide occurs. In this study, we have analyzed and compared the phenotype of two mutant cell lines, the thymoma cell line RMA-S and a small lung carcinoma cell line CMT.64, in order to address the mechanism that underlies the antigen processing deficiency of CMT.64 ceils. Unlike RMA-S cells, vesicular stomatitis virus (VSV)-infected CMT.64 cells are not recognized by specific CTL. Interferon 3: (IFN-'y) treatment of CMT.64 cells restores the ability of these cells to process and present VSV in the context of K b. We show that although CMT.64 cells express a low level of 432m, the recognition by VSV-specific CTL is not restored by increasing the amount of B2m synthesized in CMT.64 cells. In addition, we find that CMT.64 cells express moderate levels of K b heavy chain molecules, but most of it is unstable and rapidly degraded in the absence of IFN-'y treatment. We infer that the antigen processing deficiency does not lie at the level of/32m or K b production. We find also that the mRNAs for both TAP-1 and -2 are present in RMA and RMA-S cells but are absent in uninduced CMT.64 cells. Upon IFN-'y induction, both mRNAs are highly expressed in CMT-64 cells. In addition, we find that the low molecular mass polypeptides 2 and 7, and additional components of the proteasome are induced by IFN-~/in CMT-64 cells. Finally, introduction of the rat TAP-1 gene in CMT.64 cells restores CTL recognition of VSV-in_fected cells. These results indicate that a TAP-1 homodimer may translocate peptides in the ER and explain partially the CMT.64 defect and the RMA-S phenotype. These findings link a dysfunction in the transport and/or generation of antigenic peptides to the capacity of tumor cells to evade immunosurveillance and provide a unique model system to dissect this phenomenon.
12 kD, and a peptide composed of 8-10 amino acids (1) (2) (3) (4) . Formation of the ternary complex is thought to involve transport into the lumen of the endoplasmic reticulum (ELL) of peptides generated by protein degradation in the cytoplasm (5) (6) (7) . The study of mutant cell lines selected for their low expression of MHC class I molecules at the cell surface has provided insights into the molecular events required for antigen processing. These studies have allowed the identification of two genes located in the MHC region which encode proteins of the ATP binding cassette (ABC) family. These genes, called transporters associated with antigen processing 1 and 2 (TAP-1 and -2) have been implicated in transport of peptides from the cytoplasm to the lumen of the ER (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Two other MHC linked genes, low molecular mass polypeptides 2 and 7 (LMP-2 and -7) (18) , are components of the proteasome, a cytoplasmic multicatalytic protease complex, that is likely responsible for some aspects of protein degradation for antigen processing (19) (20) (21) (22) (23) (24) (25) .
The mouse mutant lymphoma cell line RMA-S expresses low levels of class I molecules at the cell surface compared to the wild-type RMA cells (26, 27) . Influenza virus-infected RMA-S cells present influenza peptides in the context of D s molecules ineffidently and are only weakly recognized by specific CTL (27) . Transfection with the putative transporter gene, TAP-2, complements this deficiency (28, 29) . The endogenous TAP-2 gene of RMA-S cells was shown to contain a point mutation that introduces a stop translation codon resulting in an incomplete and defective TAP-2 protein (30) . Despite the defective TAP-2 protein in ILMA-S cells, antigenic peptides from vesicular stomatitis virus (VSV) bypass the defect and are presented to specific CTL by K b molecules in RMA-S cells (31, 32) . The VSV-nucleocapsid (N) peptide, VSV-N 52-59, was shown earlier to be the major peptide presented by K ~ molecules on VSV-infected cells (1) . The presence of the wild-type TAP-1 protein in RMA-S cells may be sufficient for translocation of the VSV-N 52-59 peptide to the ER lumen (28) (29) (30) . Alternatively, the VSV-N 52-59 peptide may not need a functional transporter for transport into the lumen of the EK. Expression of minigene-encoded viral peptide epitopes in T2 cells (33) and in vitro translation and translocation using microsomes from T2 cells (34) support this contention.
A separate class of antigen-processing variants are those in which the assembly and the surface expression of MHC class I molecules are entirely inducible by IFN-~/ (35) . For example, in the small lung carcinoma cell line CMT.64, recognition by influenza virus-specific CTL does not take place unless induced with IFN-3~ (36) . The very low amount of all proteasome components present in uninduced CMT.64 cells is presumed to be responsible for their phenotype (19) . Exogenous influenza peptides can bind to D b molecules on CMT.64 cells and complement recognition by influenzaspecific CTL (36) . In addition, we have found that ~2m and the VSV-N 52-59 peptides added exogenously to these cells complement recognition by VSV-specific CTL restricted to K b (37) . The amount of B2m and of heavy chains synthesized in these cells may limit the amount of MHC class I expression on the cell surface (37) . A dysfunction of the putative peptide transporters and/or in the generation of the peptide may be responsible for the CMT.64 phenotype which may represent a mechanism to downregnlate MHC class I expression, a feature common to many carcinomas.
RMA, RMA-S, and CMT.64 cells originate from the same strain of mice, C57B1/6, and therefore should have the same transporter genes with identical properties regarding the peptide delivery to D b and K b molecules unless mutated or downregulated (26, 35) . This therefore gives us the opportunity to examine the constituents of antigen processing in a controlled system. In this paper, we show that RMA-S and CMT.64 cells have a different phenotype regarding VSV antigen processing and presentation with K b molecules. We have followed the expression of heavy and light chains, transporters (TAP-1 and -2), and proteasome components (LMP-2 and -7) in RMA, ILMA-S, and CMT.64 IFN-3, induced or uninduced cells and we have compared the phenotype of RMA-S and CMT.64 cells regarding antigen presentation in the context of K b molecules. These data revise the interpretation of the molecular basis of the antigen-processing deficiency in the carcinoma cells CMT.64. In addition, we have reintroduced several components of the antigen processing machinery in order to examine their ability to complement the CMT.64 phenotype.
Materials and Methods
Animals and Viruses. C57Bl/6 mice were bred at the University of British Columbia breeding facility. Mice were 6-12-wk-old and were maintained in accordance with the guidelines of the Canadian Coundl on Animal Care. VSV was grown on Veto cell monolayers. Vaccinia and a human flon (hflzm) vaccinia recombinant were generous gifts from Dr. J. Yewdell (National Institutes of Health, Bethesda, MD).
Cell Lines and Antibodies. CMT.64 cells (H-2b), graciously provided by Dr. L. M. Franks (Imperial Cancer Research Fund, London, UK), RMA, and RMA-S ceils were maintained in DMEM supplemented with 10% heat inactivated FCS, 20 mM Hepes, 2 mM glutamine, and antibiotics. The mAbs used were as follows: 142-23. PMSF (a protease inhibitor) was added to a final concentration of 20 #g/ml before use. After 15 min on ice, particulate material was removed by centrifugation. The supernatant was used for immunoprecipitation of labeled antigens. Labeled solubilized antigens were first precleared with 2 #1 of normal rabbit serum for 45 rain at 4~ followed by 50 #1 of protein A-Sepharose (1:1 in solubilization buffer) for another 45 min at 4~ Protein A-Sepharose was removed by a quick centrifugation. The precleared supernatant was reacted with the appropriate antibody or immune serum for 1 h at 4~ 35 #1 of protein A-Sepharose was added and incubation continued for a further 30 rain. After centrifugation, the beads were washed twice with 0.2% NP-40 in 10 mM Tris-HC1, pH 7.5, 0.15 M NaC1, and 2 mM EDTA, once with 0.2% NP-40 in 10 mM Tris-HC1, pH 7.5, 0.5 M NaC1, 2 mM EDTA, and finally with 10 mM Tris-HC1, pH 7.5. One-dimensional isoelectric focusing was performed as previously described (41) . SDS-PAGE was carfled out as described (42) .
CTL Response Against VSV-infected, IFN-7-induced Cells. KMA,
KMA-S, and CMT.64 cells were treated with or without IFN-'y at 200 U/ml for 48 h. They were subsequently washed three times with PBS and treated with VSV at a multiplicity of infection (MOI) of 5 in 0.5 ml,ofmedium for 1 h. The cultures were then incubated in a total of 3 ml of growth medium for an additional 4-8 h (as indicated), to allow infection to proceed. Single cell suspensions were treated with 100 #Ci 51Cr per 106 cells for 2 h in KPMI 1640 supplemented with L-glutamine and penicillin/streptomycin in the absence of fetal bovine serum (FBS) and sodium bicarbonate. Alternatively, CMT.64 cells were infected with vaccinia (V), and/or vaccinia-hfl2m (Vb2) at an MOI of 5 for 5 h followed by superinfection with VSV (MOI, 5) for an additional 4 h. The cells were washed 3 x and subsequently incubated at 104 cells per well in 96-well plates with the effector population at ratios of 100:12.5. Mockinfected cells were used as negative controls. The effector CTL population was generated by immunizing C57B1/6 mice with VSV at 5 x 106-1 x 107 Tissue culture infection dose 50% in the foot pads and ears. On day 5 after immunization, the draining lymph nodes (retropharyngeal and popliteal) were harvested and cultures initiated at 4 x 106 cells/ml in a total volume of 5 ml in 6-well plates. The culture medium consisted of RPMI-1640 supplemented with 5 x 10 -s M 2-ME, 10% heat-inactivated FBS, sodium pyruvate, penicillin, streptomycin, L-glutamine, Hepes, sodium bicarbonate, and 50% NCTC-109. Cultures were incubated for 3 d at 37~ and 5% CO2 in the absence of exogenous stimulation. The SlCr-release was measured by ~r compugamma counter (model 1282 CS; LKB Instruments, Gaithersburg, MD) and the specific S~Cr-release calculated as [(experimental -media control)/(total -media control)] x 100%. The spontaneous release never exceeded 17% of the maximum release.
RNA Extraction and Northem Analysis.
Total cellular KNA was prepared from cell lines using guanidinium isothiocyanate (GITC). Briefly, the cells were lysed in 4 M GITC then centrifuged (130,000 g for 16 h at 23~ through a cushion of cesium chloride. After ethanol precipitation, the purified RNA was resuspended in diethyl pyrocarbonate-treated H20. 10 #g of each sample was loaded and separated on a 1% agarose gel containing 2.2 M formaldehyde. The gel was blotted onto Hybond N (Amersham Corp., Arlington Heights, IL) and U/V fixed before hybridization. The 32P-labeled probes used for hybridization were as follows: MTP1 and MTP2 (TAP-1 and -2 respectively, kindly provided by Dr. GeoffButcher), prepared by random priming, and an oligonucleotide specific for fl:actin labeled by terminal transferase. Hybridization was carried out at 42~ in buffer containing 0.4 M Na2HPO4, 50% formamide, and 7% SDS. Several washes were performed at 42~ under conditions of increasing stringency and the filter exposed to X-OMAT AR film (Eastman Kodak) overnight.
Results and Discussion
The small lung carcinoma cell line, CMT.64, was shown to express and assemble M H C class I molecules on the cell surface after IFN-3, treatment (35) (36) (37) . To understand the molecular deficiency in antigen processing of CMT.64 cells, the Fig. 1 A) , in comparison to VSV-infected CMT.64 cells which are not recognized by specific CTL unless induced by IFN-3' (Fig. 1 B) . It should be noted that RMA-S, RMA, Previous experiments have demonstrated that treatment of mutant cells with exogenous peptides and/or human 32m can stabilize "empty" class I molecules at the cell surface (27, 43, 44) . RMA, RMA-S, and CMT.64 cells uninduced or induced with IFN-3/were treated overnight with exogenous peptides VSV-N 52-59 at 50/zM in the presence or absence of human 32m. VSV-N 52-59 peptides and fl2m synergistically increase the expression of the K b conformational specific epitope recognized by 142.23.3 mAb (Table 1) (Table 1) . We conclude that CMT.64 cells express much lower amounts of empty class I molecules at the cell surface than RMA-S cells.
Earlier work (45) has shown that the presence of B2m and peptides within the lumen of the EK is necessary for efficient assembly and cell surface expression of MHC class I molecules. Fig. 2 shows that CMT.64 cells express a low amount of endogenous ~n (Fig. 2, lane 1) . IFN-'y-induced CMT.64 cells express a much higher amount of/$2m, which is comparable to the level expressed in RMA and RMA-S cells (Fig.   2, lanes 2-4) . To investigate the effect of ~2m in CMT.64 cells, we have used a recombinant vaccinia virus to increase the amount of endogenous/~2m (Fig. 3, inset) . Elevating the amount of/$2m synthesized using a recombinant vaccinia virus does not restore CTL recognition of VSV-infected CMT.64 cells (Fig. 3) . We conclude that increasing expression of B2m does not induce presentation of VSV-N peptides in the context of K b molecules. The CMT.64 antigenprocessing phenotype is not caused by the low amount of endogenous B2m.
Our previous paper (37) has shown that MHC class I heavy chains are synthesized in significant amounts in CMT.64 cells, but very few molecules are reaching the cell surface unless these cells are treated with IFN-'y. Here the transport of K b and D b molecules was examined after a pulse-chase labeling of CMT.64, RMA and RMA-S cells and SDS-PAGE analysis of the immunoprecipitated material (for K b, 142.23.3 mAb was used and for D b, 28-14-8s, an ot3-specific mAb was used) (Fig. 4) . Despite a similar amount of K b molecules synthesized in RMA and RMA-S cells (Fig. 4, 0- (Fig. 4) . To address this issue, we have used a rabbit anti-exon 8 serum directed against a conformation-independent epitope recognizing a peptide in the cytoplasmic tail of H-2K b (Fig. 5, 0 -, 0.5-, and 1-h chase time), but are unstable and mostly degraded after 8-h chase with very few molecules processed to a higher molecular weight (Fig. 5,  8-h chase time) . In induced cells, K b molecules are synthesized in higher amounts and a greater proportion of the molecules are processed to a higher molecular weight ( Next, in order to assay the function of the MHC class I molecules, the CTL recognition of CMT.64 cells IFN-3' induced or uninduced and RMA-S cells treated with exogenous peptides was examined (Fig. 6) . In a dose-dependent manner, RMA-S and CMT.64 IFN-,y-treated cells were 10,000 times more sensitive than CMT.64 cells to killing by specific CTL after 2-h treatment with exogenous peptides. These results provide evidence for the low expression of peptidereceptive MHC class I molecules on the surface of uninduced CMT.64 cells. In the dose-response on RMA-S cells, a maximum of 15,000 peptide molecules per call were needed to achieve 50% killing by specific CTL, whereas a lower threshold of 150 molecules per cell resulted in the release of 5-10% of S~Cr. These data may be explained by a high amount of receptive molecules or high af~nity of the MHC class I molecules for the peptide on the surface of RMA-S and IFNy-induced CMT-64 cells. Under the conditions of our assay, where there is no exogenous 32m, the exogenously added peptides likely stabilize the empty K b molecules which arrive at the cell surface of RMA-S before they dissociate from B2m (37, 45) . The low amount of empty K b transported in uninduced CMT.64 cells would explain the difference in sensitization to exogenous peptides. The results shown in Figs. 2-6 indicate that despite its lower expression, Bzm alone is not responsible for the lack of antigen presentation in CMT.64 cells. In addition, K b and D b molecules are synthesized in these cells but very few are transported to the cell surface where they bind exogenously added peptides. Besides heavy and light chains, peptides are necessary for the efficient assembly of MHC class I molecules in the ER (10) (11) (12) 27) . We have looked at the possibility that the absence of components responsible for the generation and transport of these peptides within the ER may be responsible for the CMT.64 phenotype.
A putative peptide transporter, presumed to be composed 4) , and RMA-S (lanes 5 and 6) cells IFN-7-induced (+) or uninduced (-) were analyzed. TAP-l, TAP-2, and 13-actin probes were hybridized with the membrane. The radioactivity bound to specific RNA sequences is detected after overnight exposure of the membrane to a XAR film.
of a heterodimer of two half-ABC type transporters called TAP-1 and -2, has been implicated in translocating peptides into the ER for MHC class I assembly (15, 16) . To characterize the difference of phenotypes between RMA-S and CMT.64 cells, the expression of TAP-1 and -2 genes in these cell lines was examined. In Fig. 7 , Northern blot analysis shows that uninduced CMT.64 cells do not express a detectable amount of TAP-1 and -2 m R N A and that the amount of these mRNAs is highly increased after IFN-3, treatment of these cells. In addition, we show that no major difference exists between TAP-1 and -2 gene expression in RMA-S and RMA cells ( formation of unstable and inefficiently transported MHC dass I complexes. Before concluding that TAP deficiencies are the likely or only defects in CMT.64 cells, we decided to examine the presence of proteasome components in these cells. Viral peptides are thought to be generated in the cytoplasm by the proteasome (19) (20) (21) (22) (23) (24) (25) before crossing the ElL membrane. The proteasome components are likely key players in antigen processing which could be absent in these cells. A rabbit anti-rat proteasome serum was used which recognizes the mouse proteasome. After immunoprecipitation of the proteasomes, the different component LMP produced in these mouse cells (Fig,  8) can be analyzed by two-dimensional gel electrophoresis. Two-dimensional gel analysis of immunoprecipitations reveals that the major components of the proteasome are not affected by IFN-3' treatment of CMT.64 cells but that seven components, including LMP-2 and -7, are missing in uninduced CMT.64 cells. According to the results of others (47), the proteins numbered 1 and 7 in Fig. 8 correspond to LMP-7 and -2, respectively. LMP-2, -7, and five other components of the proteasome are upregulated slightly by IFN-y in RMA and RMA-S cells and are induced from a state of an undetectable expression to a higher detectable level of expression in IFN-7-treated CMT.64 cells (Fig. 8) . LMP-7 (Fig. 8) is particularly highly induced in CMT.64 cells treated with IFN-% These components are not recognized in any of the cell lines used in this study by nonimmune rabbit serum (data not shown). These results contrast the results of others which suggested that CMT.64 express a low level of all proteasome components (18) and these new results indicate that these induced proteasome components may affect the activity of the proteasome and allow the generation of the VSV-N peptides in induced CMT.64 cells. Recent data (48, 49) suggest that LMP-2 and -7 may not be necessary for influenza virus antigen presentation in mutant cells transfected with the TAP-1 and -2 genes.
Our results show that IFN-3' treatment in addition to inducing transcription of TAP-1 and -2 gene also upregnlates the synthesis of seven components of the proteasomes, including LMP-2 and -7. Others describe that components in addition to LMP-2 and -7 are upregulated in Hela cell proteasomes by IFN-'y treatment (24, 47) . However, as these cells are functionally wild type, the functional ramification of this regulation has not been addressed. Furthermore, as LMP-2 and -7 are first synthesized as precursor proteins which are cleaved into smaller products (47) , it is possible that some of the five additional proteins missing from uninduced CMT.64 cells are precursor proteins of LMP-2 and -7.
Consideration of the accumulated data regarding antigen processing in RMA-S and CMT.64 cells leads to the contention that a functional TAP-1 protein homodimer alone may facilitate the transport of the VSV-N 52-59 peptide from the cytosol to the ER lumen where binding to the heavy chains takes place. An alternative explanation is that this peptide does not require a transporter for translocation across the ER membrane but is not generated in the CMT.64 cells. To more dearly define the defect affecting the recognition of VSVinfected CMT.64 cells by specific CTL, we have introduced the rat TAP-1 gene in CMT.64 cells. In Fig. 9 , we show that VSV-infected TAP-1 positive CMT.64 cells are recognized by specific CTL. On the contrary, VSV-infected CMT.64 cells transfected with the vector DNA only are not recognized by specific CTL. This result indicates that TAP-1 alone is suificient for restoration of VSV recognition in CMT.64 cells and explains the RMA-S phenotype and its apparent "leakiness" regarding VSV presentation (31, 32) . TAP-1 alone may Figure 9 . CMT 64 (CMT), CMT 64 transfected with TAP-1 (CMT TAP/), and CMT.64 transfected with the vector only (CMT Vec) were infected with or without VSV for 8 h at a MOI of 5, or treated with N52-59 peptide for 2 h at 500 pM (50% dose-response). Spontaneous release did not exceed 12%.
be sufficient for VSV presentation in tLMA-S cells and in transfected CMT.64 cells and may form a homodimer capable of translocation of spedfic peptides into the lumen of the EIL. Further studies are underway to define the role of transporter homodimers and heterodimers in peptide uanslocation during virus infection (Reid, G., lL. Gabathuler, G. Kolaitis, and W. A. Jeffcries, manuscript in preparation). In addition to transporters, the difference in the tLMA-S and CMT.64 phenotype may be explained at one level by the higher amount of viral peptides generated in RMA-S cells. As reported recently, a more dticient protein degradation machinery is present in ceils with proteasome containing aU the LMP components (including LMP-2 and -7) (50, 51) . This would cause a higher quantity of peptides to be expressed in cells expressing all the components of the proteasome. It is interesting to note that one may assume that a total repression of the expression of both LMPs and TAPs localized in the same region of class II may be suflficient for avoiding any expression of class I on the cell surface. This may be very important for some cancer cells (38, 52, 53) 
